Live from the NIH registry
Studies recruiting near Columbia right now
Top 25 of 251 recruiting studies, sorted by proximity — each links to its official registry page
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Hand Transplantation, Peripheral Nerve Injuries
N/A
Interventional 180 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
MU Health Care Goldschmidt Cancer Center — Jefferson City, Missouri (26.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Membrane Target Detection for Leukemia Treatment
Hematological Malignancy
N/A
Observational 50 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
MU Health - University Hospital/Ellis Fischel Cancer Center — Columbia, Missouri (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Implementation Supports for Improving Identification and Delivery of School-based Mental Health Supports for Middle Schools Students
Mental Health Issue
N/A
Interventional 21,350 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: University of Virginia
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Columbia, Missouri (0.5 mi)
· Sponsor: AstraZeneca
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
University of Missouri Health Care — Columbia, Missouri (0.5 mi)
· Sponsor: Duke University
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Missouri Cancer Associates — Columbia, Missouri (0.5 mi)
· Sponsor: Bristol-Myers Squibb
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
Supratentorial Hemorrhage
N/A
Observational 500 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: Integra LifeSciences Corporation
Targeting Insomnia in School Aged Children With Autism Spectrum Disorder
Insomnia Chronic, Autism Spectrum Disorder
N/A
Interventional 180 participants sought
Thompson Center for Autism and Neurodevelopmental Disorders — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
University of Missouri - Ellis Fischel Cancer Center — Columbia, Missouri (0.5 mi)
· Sponsor: Allogene Therapeutics
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Missouri Cancer Associates — Columbia, Missouri (0.5 mi)
· Sponsor: SCRI Development Innovations, LLC
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Chronic Rhinosinusitis Without Nasal Polyps
Phase 3
Interventional 84 participants sought
University of Missouri Medical Center — Columbia, Missouri (0.5 mi)
· Sponsor: Optinose US Inc.
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
University of Missouri Hospital /ID# 262562 — Columbia, Missouri (0.5 mi)
· Sponsor: AbbVie
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 2
Interventional 36 participants sought
The Curators of the University of Missouri on behalf of University of Missouri Health Care — Columbia, Missouri (0.5 mi)
· Sponsor: Takeda
Individualizing Treatment for Asthma in Primary Care (Full Study)
Asthma, Asthma Attack
Phase 4
Interventional 3,200 participants sought
University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: DARTNet Institute
Product Surveillance Registry
Cardiac Rhythm Disorders, Urological Disorders
N/A
Observational 100,000 participants sought
Research site — Columbia, Missouri (0.5 mi)
· Sponsor: Medtronic
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
MU Health - University Hospital/Ellis Fischel Cancer Center — Columbia, Missouri (0.5 mi)
· Sponsor: NRG Oncology
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Aortoiliac Occlusive Disease, Peripheral Arterial Disease
N/A
Interventional 244 participants sought
The Curators of the University of Missouri — Columbia, Missouri (0.5 mi)
· Sponsor: W.L.Gore & Associates
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 2 — Jefferson City, Missouri (26.9 mi)
· Sponsor: Arrowhead Pharmaceuticals
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Non Small Cell Lung Cancer, Esophageal Cancer
N/A
Observational 320 participants sought
Harry S Truman Veterans Memorial Hospital — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Immediate Vs. Delayed Weight Bearing Postoperative Protocol in Diabetic Ankle Fractures
Ankle Fractures
N/A
Interventional 25 participants sought
University of Missouri Health System — Columbia, Missouri (0.5 mi)
· Sponsor: Kyle Schweser MD
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
MU Health Care Goldschmidt Cancer Center — Jefferson City, Missouri (26.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Dietary Fiber Effects on the Microbiome and Satiety
Dietary Fiber
N/A
Interventional 88 participants sought
University of Missouri-Columbia — Columbia, Missouri (0.5 mi)
· Sponsor: University of Missouri-Columbia
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 3
Interventional 380 participants sought
University of Missouri Hospital /ID# 261553 — Columbia, Missouri (0.5 mi)
· Sponsor: AbbVie